Onko Bcg 50
1 ampoule or vial of Onko BCG 50 contains at least 150 mln living BCG bacilli ((Bacillus Calmette–Guérin)
Therapeutical action: The intravesical BCG administration is intended to destroy the primary tumour as well as delay or prevent its recurrence. The specific mechanism of action of BCG has not been fully explained. It is thought that its activity involves inducing the inflammatory process within the urinary bladder wall, which protects the system from cancer development and stimulates the patient’s immune system.
Indications: BCG bacilli are utilized in therapy of some cancer types as a non-specific immunostimulant. It is used in treatment of superficial, non-invasive urothelial carcinoma.
Presentation: 1 vial with powder a 50 mg + 1 ampoule with solvent a 1mL
